The Rapid Influenza Diagnostics Market is expected to reach $1.17 billion during the forecast period at a 7.9 % CAGR.
The global rapid influenza diagnostics market is anticipated to grow on account of growing prevalence of influenza coupled with rising awareness across the developed and emerging economies. In the near future, an increase in influenza awareness, especially in developed regions, would fuel global market growth. The growth of the industry will be boosted by expanded healthcare investment based on R&D for influenza detection and therapeutics. The growth of the global rapid influenza diagnostics market will be boosted by increasing awareness towards rapid influenza diagnostic tests due to several benefits, such as disease specificity & quick findings. However, the lack of trained healthcare practitioners along with many influenza virus-related mutations will hinder the market development of rapid influenza diagnostic tests over the projected timeframe.
The global rapid influenza diagnostics market is categorized based on product, and end-use. Region wise, North America was the largest market in 2019; however, Asia Pacific is expected to be the fastest growing region by 2028 owing to growing government initiatives to tackle the outbreak of influenza. Factors that are catapulting demand growth are supposed to be the introduction of digital technologies and growing recognition among people. Asian countries are strongly engaged in taking protective steps to tackle the outbreak of the disease and there is raising concern. All these factors are projected to fuel demand for rapid influenza diagnostics market across the region
Rapid Influenza Diagnostics Market Scope
| Metrics | Details |
| Base Year | 2020 |
| Historic Data | 2018-2019 |
| Forecast Period | 2021-2027 |
| Study Period | 2017-2027 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2027 | $1.17 billion |
| Growth Rate | CAGR of 7.9 % during 2021-2027 |
| Segment Covered | by Test Type, Molecular, End User, Regions |
| Regions Covered | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Key Players Profiled | Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Quidel Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Meridian Bioscience Inc. (U.S.),bioMérieux SA (France), Luminex Corporation (U.S.), Siemens Healthineers AG (Germany), GenMark Diagnostics, Inc. (U.S.), Sekisui Diagnostics, LLC (U.S.), altona Diagnostics GmbH (Germany), SA Scientific, Ltd. (U.S.), and ELITech Group (France), Coris Bioconcept SPRL (Belgium), and Mast Group Ltd.(U.K.). |
Key segments of the global rapid influenza diagnostics market
Product Overview, 2018-2028 (USD Million)
- RIDT for Influenza A
- RIDT for Influenza B
End-Use Overview, 2018-2028 (USD Million)
- Hospitals
- Diagnostics Centers
- Research Laboratories
Regional Overview, 2018-2028 (USD Million)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- South America
- Brazil
- Mexico
- Rest of South America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Important Companies in Global Rapid Influenza Diagnostics Market
- DiaSorin Molecular LLC
- BD
- SA Scientific
- Coris BioConcept
- Meridian Bioscience Inc.
- Abbott
- Analytik Jena
- F. Hoffmann-La Roche Ltd
- Quidel Corporation
- Princeton BioMeditech Corporation
Reasons for the study
- The purpose of the study is to give an exhaustive outlook of the global Rapid Influenza Diagnostics industry
- The overall segmentation of Rapid Influenza Diagnostics market, especially key segments are thoroughly studied.
- Presence of major players and their wide product portfolio across developed countries is anticipated to further boost the growth of Rapid Influenza Diagnostics market
What does the report include?
- The study on the global rapid influenza diagnostics market includes analysis of qualitative market indicators such as drivers, restraints, challenges and opportunities
- Additionally, the market competition has been evaluated using the Porter’s five forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of applications, product, technology and end user. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the considered segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global rapid influenza diagnostics market is suitable for all the players across the value chain including raw material suppliers, Rapid Influenza Diagnostics providers, diagnostic kits manufacturers, distributors, suppliers and retailers
- Venture capitalists and investors looking for more information on the future outlook of the global rapid influenza diagnostics market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global rapid influenza diagnostics market
Frequently Asked Questions (FAQ) :
To get latest version of Rapid Influenza Diagnostics Market report can be obtained on demand from the website.
The Product of the Rapid Influenza Diagnostics Market RIDT for Influenza A, RIDT for Influenza B
The base year for the report is 2021 in Rapid Influenza Diagnostics Market.